Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity

Cell Death and Differentiation

Volumn 22, Issue 3, 2015, Pages 433-444

  Menzies, F M ^a   Garcia Arencibia, M ^a,g   Imarisio, S ^b   O'Sullivan, N C ^b,h   Ricketts, T ^a   Kent, B A ^b,c   Rao, M V ^d,e,f   Lam, W ^b   Green Thompson, Z W ^a   Nixon, R A ^d,e,f   Saksida, L M ^b,c   Bussey, T J ^b,c   O 'Kane, C J ^b   Rubinsztein, D C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^h UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN; HUNTINGTIN; POLYGLUTAMINE; SMALL INTERFERING RNA; CALCIUM BINDING PROTEIN; CALPAIN A, DROSOPHILA; DROSOPHILA PROTEIN; PEPTIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CONTROLLED STUDY; DOWN REGULATION; DROSOPHILA; ENZYME INHIBITION; FEMALE; GENE SILENCING; HUNTINGTON CHOREA; MALE; MOUSE; MUTANT; NERVE DEGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; TREMOR; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUNTINGTON DISEASE; INBREEDING; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; CALCIUM-BINDING PROTEINS; CALPAIN; DISEASE MODELS, ANIMAL; DROSOPHILA; DROSOPHILA PROTEINS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUNTINGTON DISEASE; INBREEDING; MALE; MICE; MICE, INBRED C57BL; PEPTIDES; SIGNAL TRANSDUCTION;

EID: 84922506219     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.151     Document Type: Article

References (47)

1. Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C et al. Huntington's disease: from pathology and genetics to potential therapies. Biochem J 2008; 412: 191-209.
2. Ravikumar B, Vacher C, Berger Z, Davies J, Luo S, Oroz L et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004; 36: 585-595.
3. Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 2006; 15: 433-442.
4. Menzies FM, Huebener J, Renna M, Bonin M, Riess O, Rubinsztein DC. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain 2010; 133(Pt 1): 93-104.
5. Menzies FM, Moreau K, Rubinsztein DC. Protein misfolding disorders and macroautophagy. Curr Opin Cell Biol 2011; 23: 190-197.
6. Ravikumar B, Duden R, Rubinsztein D. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 2002; 11: 1107-1117.
7. Ono Y, Sorimachi H. Calpains: an elaborate proteolytic system. Biochim Biophys Acta 2012; 1824: 224-236.
8. Williams A, Sarkar S, Cuddon P, Ttofi E, Saiki S, Siddiqi F et al. Novel targets for Huntington 's disease in an mTOR-independent autophagy pathway. Nat Chem Biol 2008; 4: 295-305.
9. Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006; 8: 1124-1132.
10. Xia HG, Zhang L, Chen G, Zhang T, Liu J, Jin M et al. Control of basal autophagy by calpain1 mediated cleavage of ATG5. Autophagy 2010; 6: 61-66.
11. Friedrich P, Tompa P, Farkas A. The calpain-system of Drosophila melanogaster: coming of age. Bio Essays 2004; 26: 1088-1096.
12. Martindale D, Hackam A, Wieczorek A, Ellerby L, Wellington C, McCutcheon K et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet 1998; 18: 150-154.
13. Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem 2000; 275: 19831-19838.
14. Gafni J, Ellerby LM. Calpain activation in Huntington 's disease. J Neurosci 2002; 22: 4842-4849.
15. Gafni J, Hermel E, Young JE, Wellington CL, Hayden MR, Ellerby LM. Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus. J Biol Chem 2004; 279: 20211-20220.
16. Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S et al. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem 2010; 285: 8808-8823.
17. Zhang S, Binari R, Zhou R, Perrimon N. A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 2010; 184: 1165-1179.
18. Simonsen A, Cumming RC, Brech A, Isakson P, Schubert DR, Finley KD. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 2008; 4: 176-184.
19. Franceschini N, Kirschfeld K. [Pseudopupil phenomena in the compound eye of drosophila]. Kybernetik 1971; 9: 159-182.
20. Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, Faber PW et al. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 1998; 21: 633-642.
21. Marsh JL, Walker H, Theisen H, Zhu YZ, Fielder T, Purcell J et al. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum Mol Genet 2000; 9: 13-25.
22. Reinecke JB, DeVos SL, McGrath JP, Shepard AM, Goncharoff DK, Tait DN et al. Implicating calpain in tau-mediated toxicity in vivo. PLoS One 2011; 6: e23865.
23. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M et al. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001; 293: 711-714.
24. Rao MV, Mohan PS, Peterhoff CM, Yang DS, Schmidt SD, Stavrides PH et al. Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression. J Neurosci 2008; 28: 12241-12254.
25. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493-506.
26. Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 1997; 8: 711-713.
27. Kastenmayer RJ, Fain MA, Perdue KA. A retrospective study of idiopathic ulcerative dermatitis in mice with a C57BL/6 background. J Am Assoc Lab Ani Sci 2006; 45: 8-12.
28. Narain Y, Wyttenbach A, Rankin J, Furlong RA, Rubinsztein DC. A molecular investigation of true dominance in Huntington's disease. J Med Genet 1999; 36: 739-746.
29. Saito K, Elce JS, Hamos JE, Nixon RA. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 1993; 90: 2628-2632.
30. Sepers MD, Raymond LA. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease. Drug Discov Today 2014; 19: 990-996.
31. Siman R, Card JP, Davis LG. Proteolytic processing of beta-amyloid precursor by calpain I. J Neurosci 1990; 10: 2400-2411.
32. Mercken M, Grynspan F, Nixon RA. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Lett 1995; 368: 10-14.
33. Yang LS, Ksiezak-Reding H. Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. Eur J Biochem 1995; 233: 9-17.
34. Rao MV, McBayer MK, Campbell J, Kumar A, Hashim A, Sershen H et al. Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in Tau P301L Mice. J Neurosci 2014; 34: 9222-9234.
35. Dufty BM, Warner LR, Hou ST, Jiang SX, Gomez-Isla T, Leenhouts KM et al. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. Am J Pathol 2007; 170: 1725-1738.
36. Diepenbroek M, Casadei N, Esmer H, Saido TC, Takano J, Kahle PJ et al. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]alphaSyn transgenic mice. Hum Mol Genet 2014; 23: 3975-3989.
37. Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC. Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 2003; 278: 25009-25013.
38. Dietzl G, Chen D, Schnorrer F, Su KC, Barinova Y, Fellner M et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 2007; 448: 151-156.
39. Freeman M. Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell 1996; 87: 651-660.
40. Perrin L, Bloyer S, Ferraz C, Agrawal N, Sinha P, Dura JM. The leucine zipper motif of the Drosophila AF10 homologue can inhibit PRE-mediated repression: implications for leukemogenic activity of human MLL-AF10 fusions. Mole Cel Biol 2003; 23: 119-130.
41. Dimitroff B, Howe K, Watson A, Campion B, Lee HG, Zhao N et al. Diet and energy-sensing inputs affect TorC1-mediated axon misrouting but not TorC2-directed synapse growth in a Drosophila model of tuberous sclerosis. PLoS One 2012; 7: e30722.
42. Lin DM, Goodman CS. Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron 1994; 13: 507-523.
43. Simonsen A, Cumming R, Brech A, Isakson P, Schubert D, Finley K. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 2008; 4: 176-184.
44. Green EW, Fedele G, Giorgini F, Kyriacou CP. A Drosophila RNAi collection is subject to dominant phenotypic effects. Nat Methods 2014; 11: 222-223.
45. Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mole Genet 1999; 8: 397-407.
46. Romberg C, McTighe SM, Heath CJ, Whitcomb DJ, Cho K, Bussey TJ et al. False recognition in a mouse model of Alzheimer's disease: rescue with sensory restriction and memantine. Brain 2012; 135(Pt 7): 2103-2114.
47. Davies SW, Sathasivam K, Hobbs C, Doherty P, Mangiarini L, Scherzinger E et al. Detection of polyglutamine aggregation in mouse models. Methods Enzymol 1999; 309: 687-701.